Share Name Share Symbol Market Type Share ISIN Share Description
Moberg Pharma Ab (publ) LSE:0P48 London Ordinary Share SE0003613090 MOBERG PHARMA ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +SEK0.00 +0.00% SEK30.45 SEK0.00 SEK0.00 - - - 179 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0.00

Moberg Pharma Publishes Information Document on the Proposed Divestment of the OTC-Business

04/03/2019 7:51am

PR Newswire (US)

Moberg Pharma Ab (publ) (LSE:0P48)
Historical Stock Chart

3 Months : From Feb 2019 to May 2019

Click Here for more Moberg Pharma Ab (publ) Charts.

STOCKHOLM, March 4, 2019 /PRNewswire/ -- On February 12th, 2019, it was announced that Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has entered into agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest its entire commercial operations. Further information regarding the proposed divestment of the OTC-business has today been published and is available in the form of an information document.

The information document describes the proposed transaction as well as the Company's continued operations following a divestment of the OTC-business. The information document contains among other things financial pro forma information in the form of income statement and balance sheet for 2018, the background and reasons for the proposed divestment and detailed information regarding the different elements of the transaction.

The information document is only available in Swedish. However, the pro forma information is available in English in the form of a translation. The information document and the translation are available on the Company's website,

The published information document is to be used for information purposes only and as a basis for assessing the consequences of the proposed divestment of the OTC-business of Moberg Pharma and actions related thereto, which are described in the information document. The information document does not contain or constitute an invitation or an offer to acquire, sell, subscribe for or otherwise trade in shares or other securities in Moberg Pharma. The published information document has not been approved by any regulatory authority and is not a prospectus.


For additional information, please contact: 

Peter Wolpert, CEO
phone: Sweden: +46-707-35-7135
US: +1-908-432-2203

Anna Ljung, CFO
phone: +46-707-66-6030

About this information              

The information was submitted for publication, through the contact persons set out above, at 8.30 a.m. (CET) on March 4th, 2019. 

This information was brought to you by Cision,c2754647

The following files are available for download:

Moberg Pharma publishes information document on the proposed divestment of the OTC-business

Information Document 190304

English translation of pro forma 190304

Cision View original content:

SOURCE Moberg Pharma

Copyright 2019 PR Newswire

1 Year Moberg Pharma Ab (publ) Chart

1 Year Moberg Pharma Ab (publ) Chart

1 Month Moberg Pharma Ab (publ) Chart

1 Month Moberg Pharma Ab (publ) Chart
Your Recent History
Moberg Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190520 05:23:47